walkpad active⁴⁵ smart insole tracks COP, plantar pressure, and PTI for running, squat form, rehab, and diabetic foot monitoring with lab-grade precision.
-- AlphaBio K.K. is pleased to announce the Kickstarter launch of walkpad active⁴⁵, a new-generation smart insole for gait analysis (COP). This AI-powered wearable combines precision biomechanics and sensor fusion to redefine running gait analysis, squat form correction, rehabilitation tracking, and diabetic foot monitoring. With 45 high-density pressure sensors and a 6-axis IMU unit (provides velocity, acceleration, orientation and rotation angles) on each foot, walkpad active⁴⁵ measures Center of Pressure (COP), plantar pressure, and PTI (pressure-time integral) in real time, offering a level of data accuracy once reserved for clinical laboratories.
Designed to bring clinical-grade gait analytics into everyday life, this smart insole captures the complete biomechanics of motion rather than simple step counts. Its advanced AI algorithms analyze COP, velocity, ground contact area, and pressure distribution to identify inefficiencies, asymmetry, or risk of overload—insights that help users improve technique, balance, and recovery. Whether used for personal fitness, sports rehab, or diabetic foot monitoring, walkpad active⁴⁵ delivers measurable results grounded in scientific precision.
The system’s app synchronizes with mobile video for camera-overlay playback that shows each movement in sync with pressure heatmaps and COP paths. Developed collaboratively with fitness coaches, athletes, and rehabilitation specialists, the platform enables targeted gait correction, strength assessment, and preventive feedback. walkpad active⁴⁵ also supports SDK/API integration for clinics and research institutions, as well as future compatibility with Apple Health and Google Health Connect.
“Other insoles count steps, whereas walkpad active⁴⁵ measures your COP (Center of Pressure),” says Mindy Fang, Founder and CEO of AlphaBio K.K. “COP is the gold standard in gait analysis, and with 45 sensors plus a 6-axis IMU in each foot, walkpad active⁴⁵ brings laboratory-level precision into everyday fitness, rehabilitation, and wellness.”
The insole’s construction emphasizes durability, sustainability, and comfort. It features ortholite materials, minimal plastic-free packaging, and a flexible design. Edge-based AI processing provides low-latency feedback and BLE connectivity, while local-first data handling and encrypted synchronization ensure privacy. walkpad active⁴⁵ uses sweat-resistant material for coating, is lightweight, and designed for long-term daily use across multiple sports and health applications.
Global fulfillment is coordinated through AlphaBio’s Shenzhen supply chain, allowing rapid iteration and cost control. Backers can expect worldwide delivery beginning in February 2026 (with exceptions in remote or restricted areas), with transparent VAT and customs estimates shared prior to payment. AlphaBio provides multi-language support in English, Japanese, and Chinese, alongside regular progress updates throughout production.
The Kickstarter smart insole campaign for walkpad active⁴⁵ will be live soon in November 2025, inviting early adopters to help make clinical-grade gait analysis available to everyone. For more information, visit https://alphabio.co.jp/ or explore additional COP gait analysis & plantar pressure resources on walkpad active⁴⁵’s website.
AlphaBio believes that true innovation comes through collaboration. We welcome partnerships with universities, research labs, startups, and specific sports communities worldwide to explore new applications of gait analytics. Whether in clinical research, sports performance, or rehabilitation programs, walkpad active⁴⁵ is designed as an open platform for global co-creation.
About AlphaBio K.K.
AlphaBio K.K. is a Tokyo-based health-technology company integrating AI, biomechanics, and wearable sensors to deliver clinical-grade gait analytics to consumers and professionals. Founded in 2018 by data scientist Mindy Fang, AlphaBio’s flagship product, walkpad active⁴⁵, combines high-density pressure sensing and IMU fusion to compute Center of Pressure (COP), plantar pressure, PTI, and contact area. The walkpad active⁴⁵ platform is co-developed with coaches, athletes, and clinical experts to ensure scientific accuracy and real-world usability.
Behind the technology is a human story. Mindy Fang began her work in 2018 after collaborating with a Japanese pharmaceutical company specializing in biologics for diabetic foot. Under the mentorship of diabetic foot specialist Dr. Komoda, she was inspired to create wearable technologies that prevent chronic conditions through continuous biomechanical insight. The result is walkpad active⁴⁵; a fusion of data science, health research, and user-centered engineering.
Mindy Fang brings over two decades of experience in health data and applied AI, with a background spanning Kitasato University School of Pharmaceutical Sciences, Novartis, McKinsey, and IBM. Under her leadership, AlphaBio has received a ¥10,000,000 Japanese government innovation grant, submitted multiple algorithm patents, and initiated research collaborations in Japan and the United States.
Contact Info:
Name: Mindy Fang, Founder & CEO
Email: Send Email
Organization: AlphaBio K.K.
Phone: +81 90 6023 7530
Website: https://alphabio.co.jp/
Release ID: 89173394
If there are any deficiencies, discrepancies, or concerns regarding the information presented in this press release, we kindly request that you promptly inform us by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team is committed to addressing any identified issues within 8 hours to guarantee the delivery of accurate and reliable content to our esteemed readers.
